{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T02:32:47Z","timestamp":1771468367855,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Key Project of Philosophy and Social Science Research in Colleges and Universities in Jiangsu Province","award":["2022SJZD141"],"award-info":[{"award-number":["2022SJZD141"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81872711"],"award-info":[{"award-number":["81872711"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>To construct two prognostic models to predict survival in breast cancer patients; to compare the efficacy of the two models in the whole group and the advanced human epidermal growth factor receptor-2-positive (HER2+) subgroup of patients; to conclude whether the Hybrid Bayesian Network (HBN) model outperformed the logistics regression (LR) model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this paper, breast cancer patient data were collected from the SEER database. Data processing and analysis were performed using Rstudio 4.2.0, including data preprocessing, model construction and validation. The L_DVBN algorithm in Julia0.4.7 and bnlearn package in R was used to build and evaluate the HBN model. Data with a diagnosis time of 2018(n\u2009=\u200923,384) were distributed randomly as training and testing sets in the ratio of 7:3 using the leave-out method for model construction and internal validation. External validation of the model was done using the dataset of 2019(n\u2009=\u20098128). Finally, the late HER2\u2009+\u2009patients(n\u2009=\u2009395) was selected for subgroup analysis. Accuracy, calibration and net benefit of clinical decision making were evaluated for both models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The HBN model showed that seventeen variables were associated with survival outcome, including age, tumor size, site, histologic type, radiotherapy, surgery, chemotherapy, distant metastasis, subtype, clinical stage, ER receptor, PR receptor, clinical grade, race, marital status, tumor laterality, and lymph node. The AUCs for the internal validation of the LR and HBN models were 0.831 and 0.900; The AUCs for the external validation of the LR and HBN models on the whole population were 0.786 and 0.871; the AUCs for the external validation of the two models on the subgroup population were 0.601 and 0.813.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The accuracy, net clinical benefit, and calibration of the HBN model were better than LR model. The predictive efficacy of both models decreased and the difference was greater in advanced HER2\u2009+\u2009patients, which means the HBN model had higher robustness and more stable predictive performance in the subgroup.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12911-023-02224-1","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T12:02:47Z","timestamp":1689249767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prognostic models for breast cancer: based on logistics regression and Hybrid Bayesian Network"],"prefix":"10.1186","volume":"23","author":[{"given":"Fan","family":"Su","sequence":"first","affiliation":[]},{"given":"Jianqian","family":"Chao","sequence":"additional","affiliation":[]},{"given":"Pei","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Bowen","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Zongyu","family":"Luo","sequence":"additional","affiliation":[]},{"given":"Jiaying","family":"Han","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2023,7,13]]},"reference":[{"issue":"2","key":"2224_CR1","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s10142-023-01007-1","volume":"23","author":"Z Wang","year":"2023","unstructured":"Wang Z, Mehmood A, Yao J, Zhang H, Wang L, Al-Shehri M, et al. Combination of furosemide, gold, and dopamine as a potential therapy for breast cancer. Funct Integr Genom. 2023;23(2):94.","journal-title":"Funct Integr Genom"},{"issue":"3","key":"2224_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"03","key":"2224_CR3","first-page":"284","volume":"48","author":"Z Ziwei","year":"2020","unstructured":"Ziwei Z, Yongqiang Y. Clinical observation of the chemotherapy-resistant effect on Pyrotinib combined Huaier Granule in treatment of advanced breast cancer with human epidermal growth factor receptor-2 positive. Clin J Med Officers. 2020;48(03):284\u20136.","journal-title":"Clin J Med Officers"},{"key":"2224_CR4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4137\/BIC.S9455","volume":"5","author":"M Kittaneh","year":"2013","unstructured":"Kittaneh M, Montero AJ, Gl\u00fcck S. Molecular profiling for breast cancer: a comprehensive review. Biomark Cancer. 2013;5:61\u201370.","journal-title":"Biomark Cancer"},{"key":"2224_CR5","doi-asserted-by":"crossref","unstructured":"Eljack S, Allard-Vannier E, Misericordia Y, Herv\u00e9-Aubert K, Aubrey N, Chourpa I et al. Combination of Nanovectorized siRNA Directed against Survivin with Doxorubicin for efficient anti-cancer activity in HER2 + breast Cancer cells. Pharmaceutics. 2022;14(11).","DOI":"10.3390\/pharmaceutics14112537"},{"issue":"11","key":"2224_CR6","first-page":"1351","volume":"51","author":"C Jie","year":"2022","unstructured":"Jie C, Xin L. Correlation between fibrinogen to albumin ratio and efficacy of neoadjuvant chemotherapy for hormone receptor-positive\/human epidermal growth factor receptor 2-negative breast cancer. Shaanxi Med J. 2022;51(11):1351\u20134.","journal-title":"Shaanxi Med J"},{"issue":"10","key":"2224_CR7","first-page":"52","volume":"19","author":"W Jingyan","year":"2022","unstructured":"Jingyan W, Feifei X. Effect of Trastuzumab combined with conventional chemotherapy on peripheral blood T lymphocyte subsets and survival rate in patients with HER2-positive advanced breast Cancer. Chin J Ration Drug Use. 2022;19(10):52\u20136.","journal-title":"Chin J Ration Drug Use"},{"issue":"6","key":"2224_CR8","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/00005650-199906000-00009","volume":"37","author":"ST Fleming","year":"1999","unstructured":"Fleming ST, Rastogi A, Dmitrienko A, Johnson KD. A comprehensive prognostic index to predict survival based on multiple comorbidities: a focus on breast cancer. Med Care. 1999;37(6):601\u201314.","journal-title":"Med Care"},{"issue":"02","key":"2224_CR9","first-page":"3","volume":"32","author":"S Hua","year":"2022","unstructured":"Hua S, Yumei Z, Jing C, Lina C, Shubiao W. Effect of pyrrolidinib on clinical efficacy, tumor markers, Immunoglobulin Level and 1-year Survival Rate of Elderly patients with HER-2 positive advanced breast Cancer. J Shanxi Health Vocat Coll. 2022;32(02):3\u20134.","journal-title":"J Shanxi Health Vocat Coll"},{"issue":"3","key":"2224_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.artmed.2003.11.001","volume":"30","author":"PJ Lucas","year":"2004","unstructured":"Lucas PJ, van der Gaag LC, Abu-Hanna A. Bayesian networks in biomedicine and health-care. Artif Intell Med. 2004;30(3):201\u201314.","journal-title":"Artif Intell Med"},{"key":"2224_CR11","doi-asserted-by":"publisher","first-page":"101912","DOI":"10.1016\/j.artmed.2020.101912","volume":"107","author":"S McLachlan","year":"2020","unstructured":"McLachlan S, Dube K, Hitman GA, Fenton NE, Kyrimi E. Bayesian networks in healthcare: distribution by medical condition. Artif Intell Med. 2020;107:101912.","journal-title":"Artif Intell Med"},{"key":"2224_CR12","doi-asserted-by":"crossref","unstructured":"Khademi M, Nedialkov NS, Ieee, editors. Probabilistic Graphical Models and Deep Belief Networks for Prognosis of Breast Cancer. IEEE 14th International Conference on Machine Learning and Applications ICMLA; 2015 Dec 09\u201311; Miami, FL2015.","DOI":"10.1109\/ICMLA.2015.196"},{"key":"2224_CR13","doi-asserted-by":"crossref","unstructured":"Bandyopadhyay S, Wolfson J, Vock DM, Vazquez-Benitez G, Adomavicius G, Elidrisi M, et al. Data Min Knowl Disc. 2015;29(4):1033\u201369. Data mining for censored time-to-event data: a Bayesian network model for predicting cardiovascular risk from electronic health record data.","DOI":"10.1007\/s10618-014-0386-6"},{"issue":"1","key":"2224_CR14","doi-asserted-by":"publisher","first-page":"11512","DOI":"10.1038\/s41598-017-11196-y","volume":"7","author":"Y Jiao","year":"2017","unstructured":"Jiao Y, Wang XH, Chen R, Tang TY, Zhu XQ, Teng GJ. Predictive models of minimal hepatic encephalopathy for cirrhotic patients based on large-scale brain intrinsic connectivity networks. Sci Rep. 2017;7(1):11512.","journal-title":"Sci Rep"},{"key":"2224_CR15","doi-asserted-by":"crossref","unstructured":"Gr\u00fcnwald PD. The minimum description length principle. MIT press; 2007.","DOI":"10.7551\/mitpress\/4643.001.0001"},{"key":"2224_CR16","unstructured":"Friedman N, Goldszmidt M, editors. Discretizing continuous attributes while learning bayesian networks. ICML; 1996."},{"issue":"6","key":"2224_CR17","doi-asserted-by":"publisher","first-page":"e1003676","DOI":"10.1371\/journal.pcbi.1003676","volume":"10","author":"MJ McGeachie","year":"2014","unstructured":"McGeachie MJ, Chang HH, Weiss ST. CGBayesNets: conditional gaussian bayesian network learning and inference with mixed discrete and continuous data. PLoS Comput Biol. 2014;10(6):e1003676.","journal-title":"PLoS Comput Biol"},{"issue":"3","key":"2224_CR18","doi-asserted-by":"crossref","first-page":"e1452","DOI":"10.1002\/widm.1452","volume":"12","author":"T Le Quy","year":"2022","unstructured":"Le Quy T, Roy A, Iosifidis V, Zhang W, Ntoutsi E. A survey on datasets for fairness-aware machine learning. WIREs Data Min Knowl Discov. 2022;12(3):e1452.","journal-title":"WIREs Data Min Knowl Discov"},{"key":"2224_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1613\/jair.5371","volume":"59","author":"YC Chen","year":"2017","unstructured":"Chen YC, Wheeler TA, Kochenderfer MJ. Learning discrete bayesian networks from continuous data. J Artif Intell Res. 2017;59:103\u201332.","journal-title":"J Artif Intell Res"},{"key":"2224_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ijar.2019.09.002","volume":"115","author":"T Talvitie","year":"2019","unstructured":"Talvitie T, Eggeling R, Koivisto M. Learning bayesian networks with local structure, mixed variables, and exact algorithms. Int J Approximate Reasoning. 2019;115:69\u201395.","journal-title":"Int J Approximate Reasoning"},{"issue":"4","key":"2224_CR21","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s10689-013-9646-7","volume":"12","author":"G Plakhins","year":"2013","unstructured":"Plakhins G, Irmejs A, Gardovskis A, Subatniece S, Liepniece-Karele I, Purkalne G, et al. Underestimated survival predictions of the prognostic tools adjuvant! Online and PREDICT in BRCA1-associated breast cancer patients. Fam Cancer. 2013;12(4):683\u20139.","journal-title":"Fam Cancer"},{"issue":"12","key":"2224_CR22","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1200\/JCO.2005.06.178","volume":"23","author":"IA Olivotto","year":"2005","unstructured":"Olivotto IA, Bajdik CD, Ravdin PM, Speers CH, Coldman AJ, Norris BD, et al. Population-based validation of the prognostic model ADJUVANT! For early breast cancer. J Clin Oncol. 2005;23(12):2716\u201325.","journal-title":"J Clin Oncol"},{"issue":"3","key":"2224_CR23","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s10549-021-06310-8","volume":"189","author":"JY Kim","year":"2021","unstructured":"Kim JY, Jeon E, Kwon S, Jung H, Joo S, Park Y, et al. Prediction of pathologic complete response to neoadjuvant chemotherapy using machine learning models in patients with breast cancer. Breast Cancer Res Treat. 2021;189(3):747\u201357.","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"2224_CR24","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/bjc.2012.338","volume":"107","author":"GC Wishart","year":"2012","unstructured":"Wishart GC, Bajdik CD, Dicks E, Provenzano E, Schmidt MK, Sherman M, et al. PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2. Br J Cancer. 2012;107(5):800\u20137.","journal-title":"Br J Cancer"},{"issue":"05","key":"2224_CR25","first-page":"728","volume":"36","author":"J Yulong","year":"2019","unstructured":"Yulong J, Jie Z, Ying C, Yi S. Study of a comprehensive evaluation system for clinical prediction models. Chin J Health Stat. 2019;36(05):728\u201330.","journal-title":"Chin J Health Stat"},{"issue":"29","key":"2224_CR26","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1093\/eurheartj\/ehu207","volume":"35","author":"EW Steyerberg","year":"2014","unstructured":"Steyerberg EW, Vergouwe Y. Towards better clinical prediction models: seven steps for development and an ABCD for validation. Eur Heart J. 2014;35(29):1925\u201331.","journal-title":"Eur Heart J"},{"issue":"2","key":"2224_CR27","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.surg.2015.08.006","volume":"159","author":"EA Asare","year":"2016","unstructured":"Asare EA, Liu L, Hess KR, Gordon EJ, Paruch JL, Palis B, et al. Development of a model to predict breast cancer survival using data from the National Cancer Data Base. Surgery. 2016;159(2):495\u2013502.","journal-title":"Surgery"},{"issue":"1","key":"2224_CR28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13058-019-1172-6","volume":"21","author":"CC Huang","year":"2019","unstructured":"Huang CC, Chan SY, Lee WC, Chiang CJ, Lu TP, Cheng SH. Development of a prediction model for breast cancer based on the national cancer registry in Taiwan. Breast Cancer Res. 2019;21(1):92.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"2224_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13058-017-0852-3","volume":"19","author":"FJ Candido Dos Reis","year":"2017","unstructured":"Candido Dos Reis FJ, Wishart GC, Dicks EM, Greenberg D, Rashbass J, Schmidt MK, et al. An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation. Breast Cancer Res. 2017;19(1):58.","journal-title":"Breast Cancer Res"},{"issue":"2","key":"2224_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/designs2020013","volume":"2","author":"W Yue","year":"2018","unstructured":"Yue W, Wang Z, Chen H, Payne A, Liu X. Machine learning with applications in breast Cancer diagnosis and prognosis. Designs. 2018;2(2):13.","journal-title":"Designs"},{"issue":"1","key":"2224_CR31","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s12859-022-04965-8","volume":"23","author":"E Taghizadeh","year":"2022","unstructured":"Taghizadeh E, Heydarheydari S, Saberi A, JafarpoorNesheli S, Rezaeijo SM. Breast cancer prediction with transcriptome profiling using feature selection and machine learning methods. BMC Bioinformatics. 2022;23(1):410.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"2224_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0933-3657(02)00086-6","volume":"27","author":"JM Jerez-Aragon\u00e9s","year":"2003","unstructured":"Jerez-Aragon\u00e9s JM, G\u00f3mez-Ruiz JA, Ramos-Jim\u00e9nez G, Mu\u00f1oz-P\u00e9rez J, Alba-Conejo E. A combined neural network and decision trees model for prognosis of breast cancer relapse. Artif Intell Med. 2003;27(1):45\u201363.","journal-title":"Artif Intell Med"},{"issue":"2","key":"2224_CR33","doi-asserted-by":"publisher","first-page":"230","DOI":"10.4048\/jbc.2012.15.2.230","volume":"15","author":"W Kim","year":"2012","unstructured":"Kim W, Kim KS, Lee JE, Noh D-Y, Kim S-W, Jung YS, et al. Development of novel breast Cancer Recurrence Prediction Model using support Vector Machine. J Breast Cancer. 2012;15(2):230\u20138.","journal-title":"J Breast Cancer"},{"key":"2224_CR34","doi-asserted-by":"publisher","first-page":"944569","DOI":"10.3389\/fonc.2022.944569","volume":"12","author":"G Zhang","year":"2022","unstructured":"Zhang G, Shi Y, Yin P, Liu F, Fang Y, Li X, et al. A machine learning model based on ultrasound image features to assess the risk of sentinel lymph node metastasis in breast cancer patients: applications of scikit-learn and SHAP. Front Oncol. 2022;12:944569.","journal-title":"Front Oncol"},{"key":"2224_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.asoc.2013.09.014","volume":"20","author":"K-J Wang","year":"2014","unstructured":"Wang K-J, Makond B, Chen K-H, Wang K-M. A hybrid classifier combining SMOTE with PSO to estimate 5-year survivability of breast cancer patients. Appl Soft Comput. 2014;20:15\u201324.","journal-title":"Appl Soft Comput"},{"issue":"2","key":"2224_CR36","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s42979-022-01536-9","volume":"4","author":"N Aidossov","year":"2023","unstructured":"Aidossov N, Zarikas V, Zhao Y, Mashekova A, Ng EYK, Mukhmetov O, et al. An Integrated Intelligent System for breast Cancer detection at early stages using IR images and machine learning methods with explainability. SN Comput Sci. 2023;4(2):184.","journal-title":"SN Comput Sci"},{"issue":"1","key":"2224_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4258\/jksmi.2009.15.1.49","volume":"15","author":"JP Choi","year":"2009","unstructured":"Choi JP, Han TH, Park RW. A hybrid bayesian network model for predicting breast cancer prognosis. J Korean Soc Med Inf. 2009;15(1):49\u201357.","journal-title":"J Korean Soc Med Inf"},{"issue":"14","key":"2224_CR38","doi-asserted-by":"publisher","first-page":"e184","DOI":"10.1093\/bioinformatics\/btl230","volume":"22","author":"O Gevaert","year":"2006","unstructured":"Gevaert O, Smet FD, Timmerman D, Moreau Y, Moor BD. Predicting the prognosis of breast cancer by integrating clinical and microarray data with bayesian networks. Bioinformatics. 2006;22(14):e184\u2013e90.","journal-title":"Bioinformatics"},{"issue":"2","key":"2224_CR39","first-page":"175","volume":"31","author":"M Vazifehdan","year":"2019","unstructured":"Vazifehdan M, Moattar MH, Jalali M. A hybrid bayesian network and tensor factorization approach for missing value imputation to improve breast cancer recurrence prediction. J King Saud Univ - Comput Inform Sci. 2019;31(2):175\u201384.","journal-title":"J King Saud Univ - Comput Inform Sci"},{"key":"2224_CR40","doi-asserted-by":"crossref","unstructured":"Zhang D, Zhai J, Li L, Wu Y, Ma F, Xu B. Prognostic factors and a model for occult breast Cancer: a Population-Based Cohort Study. J Clin Med. 2022;11(22).","DOI":"10.3390\/jcm11226804"},{"key":"2224_CR41","doi-asserted-by":"publisher","first-page":"953992","DOI":"10.3389\/fpubh.2022.953992","volume":"10","author":"X Meng","year":"2022","unstructured":"Meng X, Hao F, Ju Z, Chang X, Guo Y. Conditional survival nomogram predicting real-time prognosis of locally advanced breast cancer: analysis of population-based cohort with external validation. Front Public Health. 2022;10:953992.","journal-title":"Front Public Health"},{"key":"2224_CR42","doi-asserted-by":"publisher","first-page":"1072218","DOI":"10.1155\/2022\/1072218","volume":"2022","author":"X Wang","year":"2022","unstructured":"Wang X, Xue Y. Analysis of prognostic factors and construction of Prognostic Models for Invasive Micropapillary Carcinoma of the breast. Comput Math Methods Med. 2022;2022:1072218.","journal-title":"Comput Math Methods Med"},{"issue":"5","key":"2224_CR43","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.aller.2011.05.002","volume":"39","author":"S Dom\u00ednguez-Almendros","year":"2011","unstructured":"Dom\u00ednguez-Almendros S, Ben\u00edtez-Parejo N, Gonzalez-Ramirez AR. Logistic regression models. Allergol Immunopathol (Madr). 2011;39(5):295\u2013305.","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"282","key":"2224_CR44","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53(282):457\u201381.","journal-title":"J Am Stat Assoc"},{"issue":"4","key":"2224_CR45","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.ijrobp.2022.11.035","volume":"115","author":"SM Bentzen","year":"2023","unstructured":"Bentzen SM, Vogelius IR. Using and understanding Survival Statistics - or how we learned to Stop Worrying and Love the Kaplan-Meier Estimate. Int J Radiat Oncol Biol Phys. 2023;115(4):839\u201346.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"17","key":"2224_CR46","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa032792","volume":"350","author":"H Kato","year":"2004","unstructured":"Kato H, Ichinose Y, Ohta M, Hata E, Tsubota N, Tada H, et al. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med. 2004;350(17):1713\u201321.","journal-title":"N Engl J Med"},{"key":"2224_CR47","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3389\/fonc.2020.00604","volume":"10","author":"X Zhou","year":"2020","unstructured":"Zhou X, Yi Y, Liu Z, Zhou Z, Lai B, Sun K, et al. Radiomics-Based preoperative prediction of Lymph Node Status following neoadjuvant therapy in locally advanced rectal Cancer. Front Oncol. 2020;10:604.","journal-title":"Front Oncol"},{"issue":"02","key":"2224_CR48","first-page":"108","volume":"26","author":"J Yuquan","year":"2022","unstructured":"Yuquan J, Yanliang C, Chunmei Y, Xiang W. Value of feature selection and subgroup analysis based on radiomics in predicting prognosis of patients with lung adenocarcinoma. J Clin Med Pract. 2022;26(02):108\u201312.","journal-title":"J Clin Med Pract"},{"issue":"1","key":"2224_CR49","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12885-019-5442-6","volume":"19","author":"MT Phung","year":"2019","unstructured":"Phung MT, Tin Tin S, Elwood JM. Prognostic models for breast cancer: a systematic review. BMC Cancer. 2019;19(1):230.","journal-title":"BMC Cancer"},{"issue":"12","key":"2224_CR50","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nrclinonc.2010.170","volume":"7","author":"C Oakman","year":"2010","unstructured":"Oakman C, Santarpia L, Di Leo A. Breast cancer assessment tools and optimizing adjuvant therapy. Nat Rev Clin Oncol. 2010;7(12):725\u201332.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"2224_CR51","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.clon.2010.11.004","volume":"23","author":"V Agarwal","year":"2011","unstructured":"Agarwal V, O\u2019Neill P. Adjuvant! Online as a decision-making tool in early breast cancer\u2013a UK national survey. Clin Oncol (R Coll Radiol). 2011;23(2):159\u201360.","journal-title":"Clin Oncol (R Coll Radiol)"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-023-02224-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-023-02224-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-023-02224-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,17]],"date-time":"2023-12-17T00:46:11Z","timestamp":1702773971000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-023-02224-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,13]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2224"],"URL":"https:\/\/doi.org\/10.1186\/s12911-023-02224-1","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,13]]},"assertion":[{"value":"4 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We signed the \u201cSurveillance, Epidemiology, and End Results Program Data-Use Agreement\u201d with the requirement to use SEER database so that we ensured that this study was in anonymized form and all methods were carried out in accordance with guidelines and regulations proposed by SEER. Access to the data in this study was obtained by signing the above SEER data study agreement and therefore did not require ethics committee approval or informed consent. According to the reuse policy of SEER, all data within SEER products is free of copyright and may be reused without our permission unless otherwise indicated.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"120"}}